Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap261.45M
Enterprise Value185.30M
Trailing P/E3.02
ABEO
(NASDAQ)Abeona Therapeutics Inc.
$4.82-- (--)
Loading... - Market loading
Abeona Therapeutics (ABEO) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)621.08
Forward Price/Sales23.14
Price/Book (mrq)1.45
Price/Tangible Book (mrq)1.45
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue463.24
EV/Earnings2.25
EV/EBITDA2.06
EV/EBIT2.14
EV/FCF-2.25
Stock Price
Current price, 52-week range, and moving averages
Current Price$4.82
1-Day Change2.23%
52-Week High$7.54
52-Week Low$3.93
52-Week Change2.92%
YTD Change-13.75%
1-Year Change-2.14%
50-Day MA$4.94
200-Day MA$5.48
Avg Volume (30 day)765.86K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding54.24M
Book Value per Share$3.16
Net Cash per Share$1.36
FCF per Share$-1.52
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$24.00
Target Upside/Downside397.93%
Analyst ConsensusBuy
Analyst Count2
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin-241.00%
EBITDA Margin (ttm)22462.50%
EBIT Margin (ttm)21650.75%
Operating Margin (ttm)-20802.25%
Pretax Margin (ttm)20666.25%
Profit Margin (ttm)20587.50%
FCF Margin (ttm)-20590.00%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)48.09%
Return on Assets (ttm)35.63%
Return on Invested Capital (ttm)79.81%
Return on Capital Employed (ttm)41.45%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue400.00K
Gross Profit-964.00K
Operating Income-83.21M
Pretax Income82.67M
Net Income82.35M
EBITDA89.85M
EBIT86.60M
Diluted EPS$1.52
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-74.93M
Capital Expenditures7.43M
Free Cash Flow-82.36M
Growth Rates (YoY)
Year-over-year growth metrics
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)231.09M
Cash & Securities (mrq)82.88M
Net Cash (mrq)74.00M
Net Cash per Share$1.36
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)19.75M
Working Capital (mrq)193.95M
Total Equity (mrq)171.23M
Book Value per Share$3.16
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)9.74
Quick Ratio (mrq)9.53
Debt/Equity (mrq)0.12
Debt/EBITDA (ttm)0.22
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Ex-Dividend DateMar 31, 2000
Pay DateMar 31, 2000
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield33.15%
FCF Yield-33.15%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score0.36
Piotroski F-Score3/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$10.38
Graham Upside/Downside126.73%
Frequently Asked Questions About Abeona Therapeutics Statistics
What are the key financial metrics for ABEO?
Abeona Therapeutics Inc. (ABEO) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is ABEO's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Abeona Therapeutics is overvalued or undervalued.
How do I read ABEO's profitability ratios?
Abeona Therapeutics's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do ABEO's debt ratios indicate?
The financial health section shows Abeona Therapeutics's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is ABEO's dividend analysis?
The dividend section covers Abeona Therapeutics's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.